P131
2-year real-world outcomes�from the use of Faricimab in neovascular�age-related macular degeneration resistant to other anti-vascular endothelial growth factors.
Eslam Ahmed, Christine Goodchild, Anastasios Bisoukis, Serena Salvatore
Poster Presenter: Eslam Ahmed